2,545
Participants
Start Date
August 3, 2017
Primary Completion Date
October 11, 2017
Study Completion Date
No treatment given
Completion of a survey
Novo Nordisk Investigational Site, Edmonton
Lead Sponsor
Novo Nordisk A/S
INDUSTRY